ID: ALA4876296

Max Phase: Preclinical

Molecular Formula: C18H24N4O2

Molecular Weight: 328.42

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCOC(=O)c1cn2c3ccccc3n(CCN(CC)CC)c2n1

Standard InChI:  InChI=1S/C18H24N4O2/c1-4-20(5-2)11-12-21-15-9-7-8-10-16(15)22-13-14(19-18(21)22)17(23)24-6-3/h7-10,13H,4-6,11-12H2,1-3H3

Standard InChI Key:  IKPAAPRSPVDKTE-UHFFFAOYSA-N

Associated Targets(Human)

Transient receptor potential cation channel subfamily M member 2 348 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 328.42Molecular Weight (Monoisotopic): 328.1899AlogP: 2.81#Rotatable Bonds: 7
Polar Surface Area: 51.77Molecular Species: BASEHBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.91CX LogP: 2.57CX LogD: 0.10
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.63Np Likeness Score: -1.63

References

1. Zhao S, Zhang H, Jin H, Cai X, Zhang R, Jin Z, Yang W, Yu P, Zhang L, Liu Z..  (2021)  Design, synthesis and biological activities of benzo[d]imidazo[1,2-a]imidazole derivatives as TRPM2-specfic inhibitors.,  225  [PMID:34416664] [10.1016/j.ejmech.2021.113750]

Source